AmerisourceBergen, #8 on the Fortune 500, sets aside $150 million for its first corporate venture fund
Fortune, Leslie Donato
It was March 2020—right before the pandemic exploded—when AmerisourceBergen’s executive team first pitched the idea to the healthcare solution company’s board of directors. Their sell: It was time for AmerisourceBergen to take a more hands-on approach to working with entrepreneurs and pharmaceutical testing. The company, which is one of the top pharmaceutical distributors in the world and posted nearly $214 billion in revenue in the year ending in Sep. 2021, had previously made an occasional investment here and there. Now it wanted to parse through hundreds of investment opportunities a year and develop better insights into the market, says Leslie Donato, AmerisourceBergen’s executive vice president and Chief Strategy Officer.
For the full article, please visit Fortune.
Cencora.com is providing automated translations to assist in reading the website in languages other than English. For these translations, reasonable efforts have been made to provide an accurate translation, however, no automated translation is perfect nor is it intended to replace human translators. These translations are provided as a service to users of Cencora.com and are provided "as is." No warranty of any kind, either expressed or implied, is made as to the accuracy, reliability, or correctness of any of these translations made from English into any other language. Some content (such as images, videos, Flash, etc.) may not be accurately translated due to the limitations of the translation software.
Any discrepancies or differences created in translating this content from English into another language are not binding and have no legal effect for compliance, enforcement, or any other purpose. If any errors are identified, please contact us. If any questions arise related to the accuracy of the information contained in these translations, please refer to the English version of the page.